We previously reported on the interaction between CSMD1 and EGFR in triple-negative breast cancer and found that CSMD1 overexpression led to increased cell apoptosis following treatment with gefitinib, an EGFR inhibitor [32]. Here, CSMD1 is linked to triple-negative breast carcinoma.